Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica

Clinical and Experimental Rheumatology

Volumn 32, Issue SUPPL.82, 2014, Pages

  Muratore, Francesco ^a   Pazzola, Giulia ^a   Pipitone, Nicolò ^a   Boiardi, Luigi ^a   Salvarani, Carlo ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Giant cell arteritis; Large vessel involvement; Polymyalgia rheumatica

Indexed keywords

AZATHIOPRINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GLUCOCORTICOID; METHOTREXATE; PREDNISONE; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AORTA ANEURYSM; AORTA ARCH SYNDROME; AORTA DISSECTION; ARTERIAL WALL THICKENING; ARTERY OCCLUSION; CLAUDICATION; COLOR ULTRASOUND FLOWMETRY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG DOSE REDUCTION; FALSE POSITIVE RESULT; GIANT CELL ARTERITIS; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATIC POLYMYALGIA; UNSPECIFIED SIDE EFFECT; WEGENER GRANULOMATOSIS;

POLYMYALGIA RHEUMATICA; AGED; AORTIC DISEASES; ARTERIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; GIANT CELL ARTERITIS; HUMANS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84901915271     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. SALVARANI C, CANTINI F, HUNDER GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372: 234-45.
2. NUENNINGHOFF DM, HUNDER GG, CHRISTIANSON TJ, McCLELLAND RL, MATTESON EL: Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003; 48: 3522-31.
3. BONGARTZ T, MATTESON EL: Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 2006; 18: 10-7.
4. HEALEY LA: Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984; 13: 322-8.
5. CANTINI F, NICCOLI L, STORRI L et al.: Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004; 33: 294-301.
6. GONZÁ LEZ-GAY MA, GARCIA-PORRUA C, RIVAS MJ, RODRIGUEZ-LEDO P, LLORCA J: Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001; 60: 367-71.
7. BLOCKMANS D, De CEUNINCK L, VANDERSCHUEREN S, KNOCKAERT D, MORTELMANS L, BOBBAERS H: Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a pro spective study in 35 patients. Rheumatology (Oxford) 2007; 46: 672-7.
8. YAMASHITA H, KUBOTA K, TAKAHASHI Y et al.: Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol 2012; 22: 705-11.
9. BLOCKMANS D, dDe CEUNINCK L, VANDERSCHUEREN S, KNOCKAERT D, MORTELMANS L, BOBBAERS H: Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006; 55: 131-7.
10. PRIETO-GONZÁ LEZ S, ARGUIS P, GARCÍ A-MARTÍ NEZ A et al.: Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012; 71: 1170-6.
11. OSTBERG G: Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand Suppl 1972; 533: 135-59.
12. LIE JT: Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995; 24: 422-31.
13. GONZALEZ-GAY MA, GARCIA-PORRUA C, PIÑ EIRO A, PEGO-REIGOSA R, LLORCA J, HUNDER GG: Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 2004; 83: 335-41.
14. GARCÍ A-MARTÍ NEZ A, HERNÁ NDEZ-RODRÍ GUEZ J, ARGUIS P et al.: Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008; 59: 422-30.
15. KLEIN RG, HUNDER GG, STANSON AW, SHEPS SG: Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83: 806-12.
16. BRACK A, MARTINEZ-TABOADA V, STANSON A, GORONZY JJ, WEYAND CM: Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42: 311-7.
17. KERMANI TA, MATTESON EL, HUNDER GG, WARRINGTON KJ: Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol 2009; 36: 2277-83.
18. SCHMIDT WA, SEIFERT A, GROMNICA-IHLE E, KRAUSE A, NATUSCH A: Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008; 47: 96-101.
19. GHINOI A, PIPITONE N, NICOLINI A et al.: Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford) 2012; 51: 730-4.
20. ASCHWANDEN M, KESTEN F, STERN M et al.: Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 2010; 69: 1356-9.
21. CZIHAL M, ZANKER S, RADEMACHER A et al.: Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol 2012; 41: 231-6.
22. CALAMIA KT, HUNDER GG: Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24: 1414-8.
23. CIMMINO MA, ZAMPOGNA G, PARODI M: Is FDG-PET useful in the evaluation of steroid-resistant PMR patients? Rheumatology (Oxford) 2008; 47: 926-7.
24. PIPITONE N, VERSARI A, SALVARANI C: Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 2008; 47: 403-8.
25. KISSIN EY, MERKEL PA: Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2004; 16: 31-7.
26. GEIGER J, BLEY T, UHL M, FRYDRYCHOWICZ A, LANGER M, MARKL M: Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis. J Magn Reson Imaging 2010; 31: 470-4.
27. BRODMANN M, LIPP RW, PASSATH A, SEINOST G, PABST E, PILGER E: The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 2004; 43: 241-2.
28. YUN M, YEH D, ARAUJO LI, JANG S, NEWBERG A, ALAVI A: F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 200; 26: 314-9.
29. BLEY TA: Imaging studies in the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S60-1.
30. BLOCKMANS D: The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 2003; 21 (Suppl. 32): S15-22.
31. STANSON AW: Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000; 18 (Suppl. 20): S43-8.
32. GHINOI A, PIPITONE N, NICOLINI A, SALVARANI C: Cranial giant cell arteritis evolving into early large-vessel vasculitis. Clin Exp Rheumatol 2008; 26 (Suppl. 49): S97-100.
33. NARVÁ EZ J, NARVÁ EZ JA, NOLLA JM, SIRVENT E, REINA D, VALVERDE J: Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) 2005; 44: 479-83.
34. MELLER J, STRUTZ F, SIEFKER U et al.: Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003; 30; 730-6.
35. BLOCKMANS D, COUDYZER W, VANDERSCHUEREN S et al.: Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008; 47: 1179-84.
36. TSO E, FLAMM SD, WHITE RD, SCHVARTZMAN PR, MASCHA E, HOFFMAN GS: Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002; 46: 1634-42.
37. ARNAUD L, HAROCHE J, MALEK Z et al.: Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 2009; 60: 1193-200.
38. De SILVA M, HAZLEMAN BL: Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 1986; 45: 136-8.
39. MAHR AD, JOVER JA, SPIERA RF et al.: Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007; 56: 2789-97.
40. CAMELLINO D, MORBELLI S, SAMBUCETI G, CIMMINO MA: Methotrexate treatment of polymyalgia rheumatica/giant cell arteritis-associated large vessel vasculitis. Clin Exp Rheumatol 2010; 28: 288-9.
41. HOFFMAN GS, CID MC, RENDT-ZAGAR KE et al.: Infliximab-GCA Study Group. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 2007; 146: 621-30.
42. CANTINI F, NICCOLI L, SALVARANI C, PADULA A, OLIVIERI I: Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum 2001; 44: 2933-5.
43. MARTÍ NEZ-TABOADA VM, RODRÍ GUEZ-VALVERDE V, CARREÑ O L et al.: A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 2008; 67: 625-30.
44. SEITZ M, REICHENBACH S, BONEL HM, ADLER S, WERMELINGER F, VILLIGER PM: Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 2011; 141: w13156.
45. SALVARANI C, MAGNANI L, CATANOSO M et al.: Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford) 2012; 51: 151-6.
46. UNIZONY S, ARIAS-URDANETA L, MILOSLAVSKY E et al.: Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken) 2012; 64: 1720-9.
47. Al-HOMOOD IA: Tocilizumab: a new therapy for large vessel vasculitis. Clin Exp Med 2013 Aug 15. [Epub ahead of print]
48. NUENNINGHOFF DM, HUNDER GG, CHRISTIANSON TJ, McCLELLAND RL, MATTESON EL: Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003; 48: 3532-7.
49. KERMANI TA, WARRINGTON KJ, CROWSON CS et al.: Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2013; 72: 1989-94.
50. PROVEN A, GABRIEL SE, ORCES C, O'FALLON WM, HUNDER GG: Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003; 49: 703-8.
51. MARTINEZ-LADO L, CALVIÑ O-DÍ AZ C, PIÑ EIRO A et al.: Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine (Baltimore) 2011; 90: 186-93.
52. MATTESON EL, GOLD KN, BLOCH DA, HUNDER GG: Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996; 100: 193-6.
53. EVANS JM, O'FALLON WM, HUNDER GG: Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122: 502-7.
54. ESPITIA O, NÉ EL A, LEUX C et al.: Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with longterm followup. J Rheumatol 2012; 39: 2157-62.
55. SCHMIDT WA, MOLL A, SEIFERT A, SCHICKE B, GROMNICA-IHLE E, KRAUSE A: Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford) 2008; 47: 1406-8.
56. ASSIE C, JANVRESSE A, PLISSONNIER D, LEVESQUE H, MARIE I: Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients. Medicine (Baltimore) 201; 90: 40-51.
57. NUENNINGHOFF DM, WARRINGTON KJ, MATTESON EL: Concomitant giant cell aortitis, thoracic aortic aneurysm, and aortic arch syndrome: occurrence in a patient and significance. Arthritis Rheum 2003; 49: 858-61.